Innate Pharma enters into a liquidity agreement with Natixis Securities

Upcoming events

5th Annual European Life Science CEO Forum (Sachs forum)
06/03/2012 - 07/03/2012

Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".

Zurich,Switzerland

More info
Smallcap Event
12/04/2012 - 13/04/2012

Paris, France

More info

Innate Pharma enters into a liquidity agreement with Natixis Securities

September 18, 2009

Innate Pharma (the Company - Euronext Paris: FR0010331421 – IPH) announces today the signature of a liquidity agreement with NatIxis Securities. The agreement will be effective September 21, 2009, for a period of one year with tacit renewal.
Innate Pharma has allocated 300,000 euros (three hundred thousands) to this contract.

Download Area
PR in english
CP en français